Evusheld was designed to protect immunocompromised people from serious cases of COVID-19, but the latest Omicron variants have rendered the drug useless.
FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans
miscellaneousmiscellaneous / miscellaneous 3 years ago 290 Views comments
Comments